Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05283967 · ClinicalTrials.gov registry record
Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults
A clinical trial of Tuberculosis, sponsored by University of Virginia.
- Completed
- Registry status
- 150
- Enrollment target
- 2
- Study locations
NCT05283967 is a study of Tuberculosis that has completed, run by University of Virginia. The registered enrollment target is 150 participants, below the 929-participant average among 29 other Tuberculosis trials with a reported enrollment target (84% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05283967, a study of Tuberculosis, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the study is to generate receiver-operating-characteristic (ROC) curves for urine colorimetry to identify tuberculosis (TB) patients (children and adults) with low drug anti-TB drug exposures, which will define the diagnostic accuracy. The central hypothesis is that urine colorimetry will successfully identify patients with low anti-TB serum drug levels, and do so with diagnostic characteristics similar to other widely used tests in TB management.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST urine colorimetric assay
Study Locations (2)
New Jersey
- Rutgers, The State University of New Jersey - Newark
Virginia
- University of Virginia - Charlottesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-01-01 |
| Est. Completion | 2023-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05283967
The ClinicalTrials.gov registry entry for NCT05283967 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 929-participant average among 29 other Tuberculosis trials with a reported enrollment target (84% lower). The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Tuberculosis appearing as the primary indexed condition, and to 1 intervention - of which urine colorimetric assay is the first listed.
NCT05283967 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New Jersey, Virginia.
Frequently Asked Questions
What is clinical trial NCT05283967 about?
NCT05283967 is a clinical study titled "Urine Colorimetry for Tuberculosis Pharmacokinetics Evaluation in Children and Adults". The purpose of the study is to generate receiver-operating-characteristic (ROC) curves for urine colorimetry to identify tuberculosis (TB) patients (children and adults) with low drug anti-TB drug exposures, which will define the diagnostic accuracy. The central hypothesis is that urine colorimetry ...
What is the current status of trial NCT05283967?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2019-01-01. Estimated completion is 2023-12-01.
What conditions does trial NCT05283967 study?
This clinical trial studies the following conditions: Tuberculosis.
What interventions are being tested in trial NCT05283967?
The interventions under investigation include: urine colorimetric assay (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05283967?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05283967 being conducted?
This trial has 2 study locations across New Jersey, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tuberculosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Training Protocol on the Natural History of Tuberculosis
RECRUITING
-
Paradoxical Tuberculosis Reactions in Patients Without HIV Infection
RECRUITING
-
PREVAIL VIIIa: Evaluation of Latent Tuberculosis Infection Screening Methods in People Living With Retroviral Infection in Liberia
ACTIVE NOT RECRUITING
-
Gene Expression in HIV and Tuberculosis Co-infection
COMPLETED
-
A Pilot Study of Methodology to Rapidly Evaluate Drugs for Bactericidal Activity, Tolerance, and Pharmacokinetics in the Treatment of Pulmonary Tuberculosis Using Isoniazid and Levofloxacin
COMPLETED · Phase 1
-
Is Tuberculin Skin Testing Effective in Screening for Latent Tuberculosis (TB) in Elderly Residents of Nursing Homes?
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.